In June 2026, we issued 48,352 shares of common stock to the Series A preferred stock holders of the Operating Partnership who exercised their option to convert their Series A preferred stock to our common stock at $2.44 per share.

During the year ended June 30, 2026, we issued 665,111 and 36,969 shares of common stock to the Series A and Series B preferred stock holders, respectively, who exercised their option to convert their shares of Series A and Series B preferred stock to shares of our common stock at prices per share ranging from $3.51 to $5.47 and $3.27 to $4.59, respectively.

During the year ended June 30, 2026, we issued 51,777.11 shares of Series A preferred stock with total gross proceeds of $1,164,985, 13,440.15 shares of Series B preferred stock with total gross proceeds of $332,488, and 54,640 shares of Series C preferred stock with total gross proceeds of $1,366,000 under the Offering Circular; and we incurred syndication costs of $761,706 in relation to common and preferred stock offerings. During the year ended June 30, 2026, we issued 8,329.62 shares of Series A preferred stock with total gross proceeds of $187,418 under the preferred stock DRIP, 1,142.15 shares of Series B preferred stock with total gross proceeds of $25,697 under the preferred stock DRIP, and 67.09 shares of Series C preferred stock with total gross proceeds of $1,508 under the preferred stock DRIP.

SHARE OFFERINGS AND FEES	12 Months Ended
Jun. 30, 2026
SHARE OFFERINGS AND FEES [Abstract]
SHARE OFFERINGS AND FEES	NOTE 12 – SHARE OFFERINGS AND FEES In June 2026, we issued 48,352 shares of common stock to the Series A preferred stock holders of the Operating Partnership who exercised their option to convert their Series A preferred stock to our common stock at $2.44 per share. During the year ended June 30, 2026, we issued 665,111 and 36,969 shares of common stock to the Series A and Series B preferred stock holders, respectively, who exercised their option to convert their shares of Series A and Series B preferred stock to shares of our common stock at prices per share ranging from $3.51 to $5.47 and $3.27 to $4.59, respectively. During the year ended June 30, 2026, we issued 51,777.11 shares of Series A preferred stock with total gross proceeds of $1,164,985, 13,440.15 shares of Series B preferred stock with total gross proceeds of $332,488, and 54,640 shares of Series C preferred stock with total gross proceeds of $1,366,000 under the Offering Circular; and we incurred syndication costs of $761,706 in relation to common and preferred stock offerings. During the year ended June 30, 2026, we issued 8,329.62 shares of Series A preferred stock with total gross proceeds of $187,418 under the preferred stock DRIP, 1,142.15 shares of Series B preferred stock with total gross proceeds of $25,697 under the preferred stock DRIP, and 67.09 shares of Series C preferred stock with total gross proceeds of $1,508 under the preferred stock DRIP. During the year ended June 30, 2026, 92,836.06 shares of Series A preferred stock with an aggregate stated value of $2,301,515 were converted into 665,111 shares of our common stock. Additionally, 6,067.10 shares of Series B preferred stock with an aggregate stated value of $151,462, together with $8,804 of accrued liquidation preference representing 9% non-cash dividends, were converted into 36,969 shares of our common stock. During the year ended June 30, 2025, no shares of common stock were issued under the common stock DRIP. Additionally, in March 2025, we issued 32.18 shares of common stock at $102.50 per share to the Class A unit holders of the Operating Partnership who exercised their option to convert their Class A units to our common share, and 15,668.10 shares of common stock to the Series A preferred stockholders who exercised their option to convert their shares of Series A preferred stock to shares of our common stock at prices per share ranging from $11.50 to $40.20. During the year ended June 30, 2025, we issued 9,044 shares of Series A preferred stock with total gross proceeds of $226,100 and 65,903.16 shares of Series B preferred stock with total gross proceeds of $1,647,579 under the Offering Circular; and we incurred syndication costs of $1,301,283 in relation to common and preferred stock offerings. During the year ended June 30, 2025, we issued 8,567.49 shares of Series A preferred stock with total gross proceeds of $192,770 under the preferred stock DRIP and 644.60 shares of Series B preferred stock with total gross proceeds of $14,503 under the preferred stock DRIP. During the year ended June 30, 2025, 12,805.38 shares of Series A preferred stock with an aggregate stated value of $318,161 were converted into 15,668.10 shares of our common stock.

During the year ended June 30, 2026, 92,836.06 shares of Series A preferred stock with an aggregate stated value of $2,301,515 were converted into 665,111 shares of our common stock. Additionally, 6,067.10 shares of Series B preferred stock with an aggregate stated value of $151,462, together with $8,804 of accrued liquidation preference representing 9% non-cash dividends, were converted into 36,969 shares of our common stock.

During the year ended June 30, 2025, no shares of common stock were issued under the common stock DRIP. Additionally, in March 2025, we issued 32.18 shares of common stock at $102.50 per share to the Class A unit holders of the Operating Partnership who exercised their option to convert their Class A units to our common share, and 15,668.10 shares of common stock to the Series A preferred stockholders who exercised their option to convert their shares of Series A preferred stock to shares of our common stock at prices per share ranging from $11.50 to $40.20.

During the year ended June 30, 2025, we issued 9,044 shares of Series A preferred stock with total gross proceeds of $226,100 and 65,903.16 shares of Series B preferred stock with total gross proceeds of $1,647,579 under the Offering Circular; and we incurred syndication costs of $1,301,283 in relation to common and preferred stock offerings. During the year ended June 30, 2025, we issued 8,567.49 shares of Series A preferred stock with total gross proceeds of $192,770 under the preferred stock DRIP and 644.60 shares of Series B preferred stock with total gross proceeds of $14,503 under the preferred stock DRIP.

During the year ended June 30, 2025, 12,805.38 shares of Series A preferred stock with an aggregate stated value of $318,161 were converted into 15,668.10 shares of our common stock.